Date: 2014-10-22 09:52:50Health Medicine Clinical medicine Ribbon symbolism RTT Breast cancer Metastatic breast cancer CCL2 Friedrich Miescher Institute for Biomedical Research Metastasis Tumor microenvironment Angiogenesis | | Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scientiAdd to Reading ListSource URL: www.fmi.chDownload Document from Source Website File Size: 30,16 KBShare Document on Facebook
|